iShares Biotechnology ETF (NASDAQ:IBB) Holdings Cut by Ferguson Wellman Capital Management Inc.

Ferguson Wellman Capital Management Inc. decreased its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 3.0% in the third quarter, Holdings Channel reports. The institutional investor owned 9,168 shares of the financial services provider’s stock after selling 285 shares during the quarter. Ferguson Wellman Capital Management Inc.’s holdings in iShares Biotechnology ETF were worth $1,335,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Williams Financial LLC bought a new position in shares of iShares Biotechnology ETF during the 2nd quarter valued at $867,000. PVG Asset Management Corp bought a new position in shares of iShares Biotechnology ETF during the 2nd quarter valued at $415,000. Avantax Advisory Services Inc. raised its holdings in shares of iShares Biotechnology ETF by 38.4% during the 1st quarter. Avantax Advisory Services Inc. now owns 5,287 shares of the financial services provider’s stock valued at $726,000 after purchasing an additional 1,466 shares in the last quarter. Concourse Financial Group Securities Inc. raised its holdings in shares of iShares Biotechnology ETF by 22.4% during the 2nd quarter. Concourse Financial Group Securities Inc. now owns 656 shares of the financial services provider’s stock valued at $90,000 after purchasing an additional 120 shares in the last quarter. Finally, Raymond James & Associates raised its holdings in shares of iShares Biotechnology ETF by 4.4% during the 2nd quarter. Raymond James & Associates now owns 189,766 shares of the financial services provider’s stock valued at $26,047,000 after purchasing an additional 7,931 shares in the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

iShares Biotechnology ETF stock opened at $140.09 on Friday. The firm’s fifty day simple moving average is $144.68 and its 200-day simple moving average is $141.56. iShares Biotechnology ETF has a 1-year low of $116.70 and a 1-year high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The firm also recently declared a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were issued a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.